DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gora-Tybor J, Medras E, Calbecka M. , et al.
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.
Leuk Lymphoma 2015;
56 (08) 2309-2314
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.